University of Delaware Among NIH 2019 Awards for High-Risk, High-Reward Research Program

“Each year, I look forward to seeing the creative approaches these researchers take to solve tough problems in biomedical and behavioral research. I am confident the 2019 cohort of awardees has the potential to advance our mission of enhancing health through their groundbreaking studies.”

NIH’s High-Risk, High-Reward Research Program funds highly innovative biomedical or behavioral research proposed by extraordinarily creative scientists. The program supports discovery by supporting potentially transformative research proposals that may struggle in the traditional review process due to their inherent risk. Researchers are encouraged to use out of the box thinking to pursue trailblazing ideas in any area of research relevant to NIH’s mission.

The High-Risk, High-Reward Research program manages the following four awards: NIH Director’s Pioneer Award, NIH Director’s New Innovator Award, NIH Director’s Transformative Research Award, and NIH Director’s Early Independence Award. For 2019, NIH awarded 93 grants that total approximately $267 million over five years. This included 11 Pioneer awards, 60 New Innovator awards, 9 Transformative Research awards, and 13 Early Independence awards for 2019. Among the winners is the University of Delaware, which was awarded a New Innovator Award. PI Dr. April Kloxin will be working on a project titled “Unraveling Fibrosis with Dynamic Microenvironments and Molecular Tools”.

Read the full article from NIH here.